IBOV 172,060.43 ▲ 0.42% IPC MEX 72,006.05 ▲ 0.16% MERVAL 2,848,945 — — USD/BRL5.62▲ 0.61% USD/MXN18.69▲ 0.48% USD/CLP991.53▲ 0.89% USD/COP3,291▼ 0.50% USD/PEN3.41▲ 0.14% USD/ARS1,547▲ 0.13% USD/UYU40.52▲ 3.32% USD/PYG6,174▲ 3.14% USD/BOB11.63▲ 1.12% USD/DOP60.60▲ 0.25% USD/CRC446.01▲ 1.79% USD/GTQ7.64▲ 3.16% USD/HNL26.90▲ 3.29% USD/NIO36.62▲ 2.73% USD/VES902.19▼ 0.13% USD/PAB1.00— 0.00% USD/BZD2.00— 0.00% USD/JMD157.49▲ 2.41% USD/TTD6.72▲ 2.22% EUR/BRL6.22▼ 0.19% BRENT 92.27 ▼ 0.53% WTI 85.90 ▼ 0.73% IRON ORE 161.91 — — COPPER 6.20 ▼ 1.12% GOLD 3,943 ▼ 1.45% SILVER 50.97 ▼ 1.77% SOY 1,228 ▼ 0.08% CORN 447.25 ▼ 0.17% WHEAT 595.50 ▼ 0.67% COFFEE 269.90 ▲ 0.33% SUGAR 18.11 ▼ 2.00% ORANGE JUICE 146.60 ▼ 0.10% COTTON 82.88 ▲ 5.55% COCOA 5,053 ▲ 2.98% BEEF 218.98 ▼ 0.10% CATTLE 332.63 ▲ 0.69% LITHIUM 61.07 ▲ 1.82% PETR4 43.55 ▼ 3.11% VALE3 64.43 ▼ 0.57% ITUB4 41.72 — 0.00% BBDC4 14.33 — 0.00% ABEV3 15.85 — 0.00% BBAS3 16.89 — 0.00% B3SA3 14.80 ▲ 2.21% WEGE3 51.61 — 0.00% PRIO3 61.47 — 0.00% SUZB3 53.80 — 0.00% RENT3 30.24 — 0.00% AZZA3 15.37 ▲ 4.34% CSAN3 3.03 — 0.00% RAIZ4 0.30 ▼ 98.60% PCAR3 2.54 — 0.00% GMAT3 4.08 ▲ 7.09% PSSA3 45.98 — 0.00% CVCB3 0.86 — 0.00% POSI3 3.32 — 0.00% SLCE3 17.05 ▼ 0.23% NATU3 5.62 — 0.00% BRKM5 2.92 — 0.00% RANI3 8.39 — 0.00% CSNA3 4.52 ▲ 3.20% IBOV 172,060.43 ▲ 0.42% IPC MEX 72,006.05 ▲ 0.16% MERVAL 2,848,945 — — USD/BRL 5.61 ▲ 0.49% USD/MXN 18.69 ▲ 0.46% USD/CLP 990.68 ▲ 0.80% USD/COP 3,289 ▼ 0.55% USD/PEN 3.41 ▲ 0.14% USD/ARS 1,545 ▲ 0.03% USD/UYU 40.52 ▲ 3.32% USD/PYG 6,174 ▲ 3.14% USD/BOB 11.63 ▲ 0.92% USD/DOP 60.60 ▲ 0.25% USD/CRC 446.01 ▲ 1.79% USD/GTQ 7.64 ▲ 3.16% USD/HNL 26.90 ▲ 3.29% USD/NIO 36.62 ▲ 2.73% USD/VES 902.19 ▼ 0.13% USD/PAB 1.00 — 0.00% USD/BZD 2.00 — 0.00% USD/JMD 157.49 ▲ 2.41% USD/TTD 6.72 ▲ 2.22% EUR/BRL 6.22 ▼ 0.19% BRENT 92.27 ▼ 0.53% WTI 85.90 ▼ 0.73% IRON ORE 161.91 — — COPPER 6.20 ▼ 1.12% GOLD 3,943 ▼ 1.45% SILVER 50.97 ▼ 1.77% SOY 1,228 ▼ 0.08% CORN 447.25 ▼ 0.17% WHEAT 595.50 ▼ 0.67% COFFEE 269.90 ▲ 0.33% SUGAR 18.11 ▼ 2.00% ORANGE JUICE 146.60 ▼ 0.10% COTTON 82.88 ▲ 5.55% COCOA 5,053 ▲ 2.98% BEEF 218.98 ▼ 0.10% CATTLE 332.63 ▲ 0.69% LITHIUM 61.07 ▲ 1.82% PETR4 43.55 ▼ 3.11% VALE3 64.43 ▼ 0.57% ITUB4 41.72 — 0.00% BBDC4 14.33 — 0.00% ABEV3 15.85 — 0.00% BBAS3 16.89 — 0.00% B3SA3 14.80 ▲ 2.21% WEGE3 51.61 — 0.00% PRIO3 61.47 — 0.00% SUZB3 53.80 — 0.00% RENT3 30.24 — 0.00% AZZA3 15.37 ▲ 4.34% CSAN3 3.03 — 0.00% RAIZ4 0.30 ▼ 98.60% PCAR3 2.54 — 0.00% GMAT3 4.08 ▲ 7.09% PSSA3 45.98 — 0.00% CVCB3 0.86 — 0.00% POSI3 3.32 — 0.00% SLCE3 17.05 ▼ 0.23% NATU3 5.62 — 0.00% BRKM5 2.92 — 0.00% RANI3 8.39 — 0.00% CSNA3 4.52 ▲ 3.20%
since 2009
Thursday, November 12, 2026

Brazil Business - Brazil

Brazil’s Rede D’Or hospital chain buys 51% of Biocor Hospital, valued at R$750 million

By · · 1 min read

RIO DE JANEIRO, BRAZIL – Rede D’Or (RDOR3) announced on Monday, April 5th, agreed to a binding memorandum of understanding to buy a 51% stake in Biocor Hospital in Belo Horizonte (MG).

Read: Massive consolidation wave looms in Brazil’s private healthcare system

The hospital has a firm value of R$750 (US$131) million, from which net indebtedness will be deducted, said the company in a material fact released to the market after the close of this trading session.

Free daily brief — no card needed
Get every Brazil story in one morning email
We build you a personalized brief around the topics you follow — free for 7 days. Love it? Your first month after that is US$1.
biocor
The transaction is still subject to verification of certain customary conditions, including approval by CADE.
RT
Ask Rio Times
Latin American markets, currencies and companies.
Open the full Ask Rio Times →

The operation is still subject to the verification of certain usual conditions, among them the approval by Brazil’s antitrust agency, the Administrative Council for Economic Defense (CADE), confirmation of due diligence, and execution of definitive instruments, including the execution of a shareholders’ agreement aiming to establish the rights and obligations of Biocor’s investors.

According to Rede D’Or, the revenue forecast for Biocor is R$300 million, with an EBITDA of R$70 million, in the 12 months following the closing of the transaction, with part of the synergies incorporated.

Source: Exame

This article was produced by The Rio Times’ automated AI newsroom. Editorial responsibility: Matthias Camenzind, Publisher and Editor-in-Chief. The Rio Times also runs Ask Rio Times, which answers from 100,000+ of our own articles, the daily Latin America Power Map, and prediction-market odds on elections and markets.. How we use AI · Report an error

The Rio Times · Power Map
See who really holds power in Latin America
Click to open the Power Map →

Brazil runoff date: Sunday, October 25, poll closing times and when results start · Brazil runoff polls: Flávio 51%, Lula 49% · Kalshi and Polymarket odds

Rotate for Best Experience

This report is optimized for landscape viewing. Rotate your phone for the full experience.